Company: AXS-PE
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001214816-25-000088
Chunk: 43

Company: AXIS CAPITAL HOLDINGS LTD
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 43
---
inancial Metrics
At the beginning of the year, the Committee approves the Company’s non-financial objectives, which are aligned with the Company's strategic business goals. At the end of the year, our CEO evaluates and makes compensation recommendations to the Committee on the performance of the other NEOs against these objectives. The Committee in turn reviews the individual performance of each NEO, considers the recommendations from our CEO (except with regard to his own individual performance) and makes a final decision for each NEO’s compensation.

#### Non-Financial Performance Achievements
The table below details the strategic business goals that were established for the Company at the beginning of 2024, and the collective accomplishments against those goals. The Human Capital and Compensation Committee considered the significant progress that was made in 2024 when assessing the portion of each NEO’s annual incentives not determined by financial targets.

#### 2024 Strategic Business Goals Performance
| Goal                                              |     | Key Accomplishments                                                                                                                                                                                                                                                                            |
| Cycle Manage to Achieve Target Portfolio          |     | •Actively responded to market conditions to optimize projected portfolio underwriting year returns, which contributed to achieving a combined ratio of 92.3%, a 7.6% reduction from the prior                                                                                                  
 •Demonstrated cycle management while hitting all profitability and growth targets                                                                                                                                                                                                              
 •Reinsurance business continued progress in achieving the right balance and portfolio mix that delivers lower volatility, a reduction in low margin business, and greater efficiency                                                                                                           
 •North America and Global Markets divisions launched new and expanded initiatives                                                                                                                                                                                                              |
| Elevate AXIS to be                                
 Recognized Leader in Specialty Markets            |     | •Achieved $9 billion gross premiums written, and exceeded our operating plan’s projected return on risk-adjusted capital                                                                                                                                                                       
 •Accelerated growth in Lower Middle Market business                                                                                                                                                                                                                                            
 •Developed an Energy Transition / Resilience offering which addresses the changing needs of this client segment and provides a Center of Excellence approach to the market                                                                                                                     
 •Advanced global leadership in specialty underwriting, and continued to find attractive opportunities for growth in our Insurance business, highlighted by the Insurance segment's 89.1% combined ratio for the full year along with overall growth of 7.7%, to reach $6.6 billion in premiums 
 •Operationalized our specialty Reinsurance business and advanced “specialty” products positioning and growth, as our Reinsurance business produced strong, consistent profits with a 91.8% combined ratio for the full year while growing 7.9% to $